Showing results (1111-1120 of 2,709) with videos related to
Sort By:
Pageof 271
The Lancet. Infectious Diseases|September 17, 2017
AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trialOusmane A Koita, Lansana Sangaré, Haiyan D Miller, et al.The Lancet. Infectious Diseases|September 19, 2017
Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort studyNathan C Bahr, Edwin Nuwagira, Emily E Evans, et al.The Lancet. Infectious Diseases|June 25, 2016
Pathogens, prejudice, and politics: the role of the global health community in the European refugee crisisMishal S Khan, Anna Osei-Kofi, Abbas Omar, et al.The Lancet. Infectious Diseases|July 5, 2016
The centenary of the discovery of trench fever, an emerging infectious disease of World War 1Gregory M AnsteadThe Lancet. Infectious Diseases|December 23, 2022
Advancing detection and response capacities for emerging and re-emerging pathogens in AfricaJean B Nachega, Sabin Nsanzimana, Angeli Rawat, et al.The Lancet. Infectious Diseases|December 25, 2022
Multinational consensus antimicrobial stewardship recommendations for children managed in hospital settingsBrendan McMullan, Penelope A Bryant, Eamon Duffy, et al.The Lancet. Infectious Diseases|June 24, 2021
Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohortPyry N Sipilä, Nelli Heikkilä, Joni V Lindbohm, et al.The Lancet. Infectious Diseases|June 25, 2021
Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort studyPeter Bager, Jan Wohlfahrt, Jannik Fonager, et al.The Lancet. Infectious Diseases|June 25, 2021
Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort studyMartina Patone, Karen Thomas, Rob Hatch, et al.The Lancet. Infectious Diseases|June 26, 2021
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort studyMadhumita Shrotri, Maria Krutikov, Tom Palmer, et al.Pageof 271